BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
9.92
0.01 (0.10%)
At close: Jun 24, 2025, 3:59 PM
9.95
0.30%
After-hours: Jun 24, 2025, 07:31 PM EDT
0.10% (1D)
| Bid | 9.7 |
| Market Cap | 2.08B |
| Revenue (ttm) | 503.49M |
| Net Income (ttm) | -53.47M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -38.15 |
| Forward PE | 25.36 |
| Analyst | Buy |
| Ask | 9.96 |
| Volume | 1,893,559 |
| Avg. Volume (20D) | 4,536,596 |
| Open | 10.05 |
| Previous Close | 9.91 |
| Day's Range | 9.75 - 10.05 |
| 52-Week Range | 6.00 - 11.31 |
| Beta | 1.10 |
About BCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BioCryst Pharmaceuticals Inc. is scheduled to release its earnings on Aug 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+23.52%
BioCryst Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
4 months ago
-9.99%
BioCryst Pharmaceuticals shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS estimate.
